This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kovács, A. F. Articles by Bitter, K. Search for Related Content PubMed PubMed Citation Articles by Kovács, A. F. Articles by Bitter, K.

Positron Emission Tomography in Combination With Sentinel Node Biopsy Reduces the Rate of Elective Neck Dissections in the Treatment of Oral and Oropharyngeal Cancer

From the Departments of Maxillofacial Plastic Surgery, Nuclear Medicine, and Neuroradiology, Johann Wolfgang Goethe-University Medical School, Frankfurt am Main, Germany

Address reprint requests to Adorján F. Kovács MD, DMD, PhD, Department of Maxillofacial Plastic Surgery, Johann Wolfgang Goethe-University Medical School, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany; e-mail: A.Kovacs{at}em.uni-frankfurt.de

PURPOSE: To assess the impact of a diagnostic ladder including [¹⁸F]fluorodeoxyglucose positron emission tomography (PET) and lymphoscintigraphy guided sentinel node biopsy (LS/SNB) on neck treatment in patients with oral and oropharyngeal squamous cell carcinoma (OOSCC).

PATIENTS AND METHODS: Prospectively, 62 patients with resectable T1-3 OOSCC underwent computed tomography (CT) and PET. Patients without neck uptake in PET were defined as cN0 and were accrued for LS/SNB. Results were correlated with histopathology. The traditional guidelines according to CT findings were compared to the actual regimen and the outcome.

RESULTS: Sensitivity, specificity, validity, and positive and negative predictive value of PET versus CT were 72% v 89%, 82% v 77%, 79% v 80.5%, 62% v 61.5%, and 88% v 94.5% (not significant). Thirty-eight PET negative patients underwent LS/SNB. Sentinel lymph nodes were found in all 38 patients. Five patients had positive nodes (PET false-negatives) and underwent neck dissection (ND). Fifty-one neck sides in 36 patients who were CT-negative would have been treated with selective ND according to the guidelines, and at least 45 neck sides would have had to undergo extensive ND because of positive CT findings (96 of 124 neck sides). In contrast, PET in combination with LS/SNB spared 59 neck sides, and 41 of 124 neck sides actually underwent ND as a result of PET staging, LS/SNB, and intraoperative decision. After a median follow-up of 35 months, two patients (both cN+ve and pN+ve) suffered from neck relapses.

CONCLUSION: Diagnostics using PET in combination with LS/SNB considerably reduced the number of extensive ND in OOSCC as compared to CT without locoregional hazard.

Authors’ disclosures of potential conflicts of interest are found at the end of this article.

This article has been cited by other articles:

				D. L. Schwartz, H. A. Macapinlac, and R. S. Weber FDG-PET Staging of Head and Neck Cancer--Can Improved Imaging Lead to Improved Treatment? J Natl Cancer Inst, May 21, 2008; 100(10): 688 - 689. [Full Text] [PDF]

				A. Tan, D. J. Adelstein, L. A. Rybicki, J. P. Saxton, R. M. Esclamado, B. G. Wood, R. R. Lorenz, M. Strome, and M. A. Carroll Ability of Positron Emission Tomography to Detect Residual Neck Node Disease in Patients With Head and Neck Squamous Cell Carcinoma After Definitive Chemoradiotherapy Arch Otolaryngol Head Neck Surg, May 1, 2007; 133(5): 435 - 440. [Abstract] [Full Text] [PDF]

				A. F. Kovacs In Reply: J. Clin. Oncol., July 20, 2005; 23(21): 4804 - 4805. [Full Text] [PDF]

				S. Pohar Positron Emission Tomography Paradigm Fuzzier Than Reported J. Clin. Oncol., July 20, 2005; 23(21): 4803 - 4804. [Full Text] [PDF]

				B. D. Smith, B. E. Lally, B. G. Haffty, and L. D. Wilson Do PET and SNB Reduce the Rate of Elective Neck Dissection? A Hypothesis Still in Need of Validation J. Clin. Oncol., April 20, 2005; 23(12): 2874 - 2875. [Full Text] [PDF]

				A. F. Kovacs In Reply: J. Clin. Oncol., April 20, 2005; 23(12): 2875 - 2876. [Full Text] [PDF]